Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Diagnos ( (TSE:ADK) ) just unveiled an update.
DIAGNOS Inc. announced the closing of a private placement, raising $2,014,610.70 through the issuance of 6,715,369 units at $0.30 each. The proceeds will support product development and commercialization of AI-based screening services, regulatory affairs, and general operations. Each unit includes a share and a warrant, with warrants exercisable at $0.40 within 18 months. The completion of this placement is subject to regulatory approvals, and securities issued are under a hold period until June 6, 2025.
More about Diagnos
DIAGNOS is a Canadian corporation specializing in early detection of critical health issues through its FLAIRE Artificial Intelligence (AI) platform. They offer innovative solutions like CARA, which provides enhanced retinal image analysis for efficient and cost-effective patient screening.
YTD Price Performance: 15.00%
Average Trading Volume: 184,497
Technical Sentiment Consensus Rating: Sell
Current Market Cap: C$32.83M
See more data about ADK stock on TipRanks’ Stock Analysis page.
